TW200536486A - Treated ganoderma lucidum and manufacturing method of processed product of ganoderma lucidum - Google Patents

Treated ganoderma lucidum and manufacturing method of processed product of ganoderma lucidum Download PDF

Info

Publication number
TW200536486A
TW200536486A TW094112843A TW94112843A TW200536486A TW 200536486 A TW200536486 A TW 200536486A TW 094112843 A TW094112843 A TW 094112843A TW 94112843 A TW94112843 A TW 94112843A TW 200536486 A TW200536486 A TW 200536486A
Authority
TW
Taiwan
Prior art keywords
ganoderma lucidum
ganoderma
processed
patent application
water
Prior art date
Application number
TW094112843A
Other languages
Chinese (zh)
Inventor
Masaaki Nakai
Yuji Nonaka
Norihiko Kageyama
Koichi Nakahara
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of TW200536486A publication Critical patent/TW200536486A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Sustainable Development (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)

Abstract

This invention provides a manufacturing method of treated Ganoderma lucidum, characterized by treating the Ganoderma lucidum with water or steam at 150~210 DEG C; and a manufacturing method of processed product of Ganoderma lucidum, characterized by processing the above treated Ganoderma lucidum through the following steps: (1) cutting or pulverizing said treated Ganoderma lucidum, (2) extracting with an aqueous solvent, and/or (3) subjecting the extract obtained from step (2) to concentration or drying to powder. According to this invention, treated Ganoderma lucidum and processed product of Ganoderma lucidum can be prepared efficiently and thus is suitable for industrial use. Furthermore, said treated Ganoderma lucidum or processed product of Ganoderma lucidum have excellent anti-tumor effect and hence is suitable for use as a medicine, a food or a drink.

Description

200536486 九、發明說明: [發明所屬之技術領域] 本發明係有關靈芝處理物或靈芝加工品之製造方法 及含有該等處理物或加工品之飲食品和醫藥品。 [先前技術] 蕈類的熱水萃取液自古傳言具有各種藥效。尤其是對 癌症有效的蕈類在中國或日本等地為已知者。科學1也正 在對此進㈣證和報告,例如非專利文獻i係揭:食用蕈 類的熱水萃取物對肉瘤(SareQma) 18G罹癌鼠具有宿主: 在性的抗腫瘤活性。 食用簟類之中’靈芝亦即(萬年茸;和 爆名. Ganodema lucidum 听)_)自古即 : 具:::藥效,特別是對癌症有效的蕈二 專利二研究,非 糖類的一種m 〜作用的活性成分是多 、 種’為/3- —D—葡聚糖。 靈芝通常利用100。。以下的熱水萃 由於此方法沾# η %付到卒取物,但 勺十取效率非常差,因此近年來 一 萃取效率的方法。 千灭係開發能提咼 J文獻1係記載以加壓熱水萃取雩^ 和水蒸氣加熱處理,記載此等處理妾著進行飽 取率為主旨。 之卒取物的萃 而 ν而言,專利文獻2係記載藉 具有捭古α 符田加壓熱水處理1 、有鈇南所得萃取物2ΝΚ活性 J作用,再者,Ιι 316979 5 200536486 θ 1 ’’’、水卞取置之,接著進行飽和水蒸氣加壓處理, 付到具有活性氧消去活性的萃取物為主旨。 再者’專利文獻3係記載以超音波粉碎蕈類後,藉 ^纖維素㈣蛋白_進行料處理,增岭帛聚糖 取量為主旨。 卞 :而上述專利文獻1至3並不十分確認抗腫瘤作用, 且W關於用以得到能表現高度抗腫瘤活性之組成物 W單靈芝加工技術。 (專利文獻1)日本專利特開平u—19681 8號公報 (專利文獻2)日本專利特開2〇〇卜187745號公報 (專利文獻3)日本專利特開2〇〇2—26282〇號公報 (非專利文獻 1) jpn j Cancer Res 59,155,1968 (非專利文獻 2) Agnc· Biol. Chem.,49, 2641,1985 [發明内容] ’ 本發明之目的係提供萃取效率良好,工業上有利的製 鲁造抗腫瘤作用優異的靈芝處理物或靈芝加工品之方法。再 者,本發明之目的係提供含有前述靈芝處理物或靈芝加工 品的飲食品或醫藥品。 本案發明者們為了達成上述目的重複致力探討的結 果,發現用150至21yC的水蒸氣處理靈芝所得到的靈芝 处理物及其加工品比習知者含有更多的水溶性0一葡聚 糖,而具有強有力的抗腫瘤作用。本案發明者們重複深入 探討而完成本發明。 亦即,本發明係有關 316979 200536486 [1]特徵為用150至210°C的水蒸氣處理靈芝的靈芝處理 物之製造方法, ’ [2]用180°C至21(TC的水蒸氣處理前述[1]的靈芝處理物 之製造方法, [3] 水蒸氣為飽和水蒸氣之前述[1]或[2]的靈芝處理物之 製造方法, [4] 於0至1 Mg/mL的氧濃度下進行處理之前述[1]至[3] 中任一項的靈芝處理物之製造方法。 鲁[5]進行水蒸氣處理1至30分鐘之前述[1]至[4]中任一項 * 的靈芝處理物之製造方法, ,[6]含有0.5重量%以上之水溶性葡聚糖的靈芝處理物。 [7] 用前述[1]至[5]中任一項的製造方法所得到之前述6的 靈芝處理物。 [8] 特徵為將以150至210°C的水蒸氣處理靈芝所得到的 靈芝處理物 1)剪切或粉末化, • 2)用水性溶劑萃取,或 3)使前述2)所得萃取液進一步濃縮提煉或乾燥粉末化。 [9] 特徵為用150至210°C的水萃取靈芝,或是使該水萃取 物進一步濃縮提煉或乾燥粉末化的靈芝加工品之製造方 法。 [10] 特徵為提取為原料靈芝之0.5重量%以上之比率的水 溶性/3-葡聚糖於靈芝加工品中的前述[9]之靈芝加工品之 製造方法, 7 316979 200536486 [11]用前述[8]、[9]或[10]之製造方法所得到的靈芝加工 品, ^ [12]含有前述[6]或[7]之靈芝處理物,或前述[11]之靈芝加 工品的飲食品, [13] 附有以抗腫瘤作用、免疫活化作用或抗癌作用為主旨 之標示之前述[12]的飲食品, [14] 含有前述[6]或[7]之靈芝處理物,或前述[11]之靈芝加 工品的醫藥品,及 籲[I5]為抗腫瘤劑之前述[I4]的醫藥品。 ' 根據本發明,能萃取效率良好,工業上有利的製造抗 .. 腫瘤作用優異的靈芝處理物或靈芝加工品。再者,根據本 / 發明,能提供含有前述抗腫瘤作用優異的靈芝處理物或靈 芝加工品之飲食品或醫藥品。 [實施方式] 本發明使用的靈芝為多孔菌科(polyporaceae)萬年茸 (Ganoderma lucidum (Fr.) Krast)的子實體。靈芝也可以相 ®同種菌,根據溫度、濕度、光度、二氧化碳濃度等生長條 件,或根據菌株的產地、系統的不同,能栽培出不同色澤 或形狀的子實體(靈芝),由色澤的不同分類為青芝、赤芝、 黃芝、白芝、紫芝、黑芝等種類,根據形狀的不同分類為 鹿角芝、牛角芝、雲芝、肉芝等種類。本發明中可使用任 一種作為上述靈芝,也可使用稱為靈芝或鹿角靈芝的市售 品作為靈芝。本發明中可使用靈芝的子實體全部,也可使 用子實體的一部分(例如經適當切斷的靈芝子實體者)作為 316979 200536486 •京料再$,上述s之通常為沒有用水或有機溶劑等處理 ,本發明中,在施加上述水蒸氣處理之前,可使上述靈 芝不與水接觸。 二 本發明之一態樣為用150至2UTC的水蒸氣處理靈芝 以製造靈芝處理物者。 “本發明中靈芝處理所用的水蒸氣,由作業性、操作性 的成點來看,係以飽和水蒸氣為較佳,但不限定於此。 處理條件只要水蒸氣溫度在150 i 21代就沒有特別 限定。在本發明方面,前述溫度範圍中係以170至21(rc 二^ 中又以180至210°c為特佳。由於水蒸氣溫度 15G°C時’抗腫瘤作用之活性成分的增大效果會降 氏’而向於2HTC時前述活性成分的增大效果也會降低, 因此並不理想。 處理時間以不妨礙本發明之目的而沒有特別限定,但 以1至3〇分鐘為限。—般而言水的溫度越高,處理時 ;且短,例如水的溫度為鐵的情況下,…。分鐘是 吾人所期望的。 少士再者’前述處理中的氧濃度並沒有特別限定,由於氧 夕4 ’因氧化分解而生成有機酸或糠醛 生影響的顧慮,因此以低氧濃度者為較佳。例如 / mL的氣濃度為吾人所期望者。 前述處理能在常壓下進行,但—般而言在加壓下進行 純佳。於加壓下進行的情況下,加壓壓力並沒有特別限 疋,使用飽和水蒸氣作為水蒸氣時的加壓壓力通常為03 316979 9 200536486 至 1.8 MPa。 上述水蒸氣處理可使用習知的處理裝置進行。處理裝 ' 置只要可進行150至210°C的水蒸氣處理就沒有特別限 定。舉例而言,可使用AKICO公司製造的高溫高壓反應 裝置或日阪製作所(股)製造的高溫濕熱處理試驗裝置 (HTS - 25/ 140-8039),瀨田興產化工(股)製造的過熱蒸氣 發生裝置(DPH GH20)等。 在本發明中,藉由對如上述所得到的靈芝處理物進一 _步施加習知的加工處理以製造靈芝加工品。例如藉由將上 ' 述靈芝處理物 - 1)剪切或粉末化, 2) 用水性溶劑萃取, 3) 使前述2)所得萃取液進一步濃縮提煉或乾燥粉末化 以製造靈芝加工品。 上述1)至3)中任一項的處理也可使用習知的手段進 行。 ® 在用上述2)的處理製造靈芝加工品的情況下,只要適 當選定萃取溫度或時間、裝置,就能藉由常用方法進行萃 取操作。上述2)的處理中用來作為萃取溶劑的水性溶劑列 舉有含水溶劑或水等。再者,也可使用高壓蒼在例如12 0 .°C下用熱水萃取。因此得到作為萃取液的靈芝加工品。 在用上述3)的處理製造靈芝加工品的情況下,例如可 藉由移除經由上述2)的處理所得到之萃取液的溶劑成為濃 縮萃取物,或者可用凍結乾燥或風乾等手段藉由使前述萃 10 316979 200536486 _取/夜乾餘成為乾燥粉末 再者 之卒取液 也可用水等溶劑稀釋經由上述2)的處理200536486 IX. Description of the invention: [Technical field to which the invention belongs] The present invention relates to a method for manufacturing Ganoderma lucidum processed products or processed products of Ganoderma lucidum and food and beverages and pharmaceutical products containing such processed products or processed products. [Prior art] Hot water extracts of mushrooms have been rumored to have various medicinal effects since ancient times. In particular, mushrooms effective for cancer are known in China and Japan. Science 1 is also supporting and reporting this. For example, the non-patent document Series I reveals that hot water extracts of edible mushrooms have host: in vivo antitumor activity against SareQma 18G cancer-bearing mice. Among the edible tadpoles, Ganoderma lucidum is also known as Wanlong Velvet; and Ganodema lucidum has been known since ancient times: With ::: Medicine effect, especially for cancer two mushrooms, two patents, two non-sugars, m ~ The active ingredient is multi-species' / 3-D-glucan. Ganoderma usually uses 100. . The following hot water extraction is because of this method, but the extraction efficiency is very poor, so it is an extraction efficiency method in recent years. The research and development of the Chimori system can improve the quality. J Document 1 describes the use of pressurized hot water extraction and steam heat treatment. In terms of the extraction of the stroke extract, Patent Document 2 describes that it has the action of the ancient fu-α-futian pressurized hot water treatment 1 and the extract 2NKK activity J from the south, and further, I 316979 5 200536486 θ 1 '' ', Take the leech, and then carry out saturated water vapor pressure treatment, and pay the extract with active oxygen elimination activity as the main purpose. Furthermore, Patent Document 3 describes that after the mushrooms are pulverized by ultrasound, the cellulose peptone is used to process the raw materials, and the main purpose is to increase the amount of the carbohydrate.卞: The above patent documents 1 to 3 do not fully confirm the antitumor effect, and are concerned with the processing technology of monolingzhi to obtain a composition capable of exhibiting high antitumor activity. (Patent Document 1) Japanese Patent Laid-Open Publication No. U-19681 No. 8 (Patent Document 2) Japanese Patent Laid-Open Patent No. 200187 187745 (Patent Literature 3) Japanese Patent Laid-Open Publication No. 2000-26282 Non-Patent Document 1) jpn j Cancer Res 59, 155, 1968 (Non-Patent Document 2) Agnc · Biol. Chem., 49, 2641, 1985 [Summary of the Invention] The object of the present invention is to provide good extraction efficiency and industrial advantage A method for producing a processed or processed Ganoderma lucidum with excellent antitumor effect. Furthermore, an object of the present invention is to provide a food or drink or a medicament containing the aforementioned processed or processed ganoderma. The inventors of the present case repeated the research results in order to achieve the above-mentioned purpose, and found that the Ganoderma lucidum processed product and its processed product obtained by treating Ganoderma lucidum with 150 to 21 μC of water vapor contain more water-soluble 0-glucan than the conventional one, And has a strong anti-tumor effect. The inventors of this case repeated the in-depth discussion to complete the present invention. That is, the present invention relates to 316979 200536486 [1] A method for manufacturing a Ganoderma lucidum treatment product characterized by treating Ganoderma lucidum with water vapor at 150 to 210 ° C, "[2] treating the foregoing with water vapor at 180 ° C to 21 ° C [1] A method for producing a ganoderma treatment product, [3] The method for producing a ganoderma treatment product of the aforementioned [1] or [2] in which water vapor is saturated water vapor, [4] an oxygen concentration of 0 to 1 Mg / mL The method for manufacturing the Ganoderma lucidum processed material according to any one of the above-mentioned [1] to [3], which is processed below. Lu [5] Any one of the above-mentioned [1] to [4], which is subjected to steam treatment for 1 to 30 minutes * [6] A method for producing a Ganoderma lucidum treated product, [6] a Ganoderma lucidum treated product containing 0.5% by weight or more of water-soluble glucan. [7] Obtained by the production method according to any one of the above [1] to [5] The Ganoderma lucidum treated product of the above 6. [8] It is characterized in that the Ganoderma lucidum processed material obtained by treating the Ganoderma lucidum with water vapor at 150 to 210 ° C 1) is sheared or powdered, • 2) is extracted with an aqueous solvent, or 3) is The extraction solution obtained in the above 2) is further concentrated and refined or dried and powdered. [9] It is characterized by the method of extracting Ganoderma lucidum with water at 150 to 210 ° C, or further concentrating the water extract, refining or drying the powdered Ganoderma lucidum processed product. [10] The method for producing the processed Ganoderma lucidum of [9] described in [9], which is characterized by extracting water-soluble / 3-glucan at a ratio of 0.5% by weight or more of the raw material Ganoderma lucidum, 7 316979 200536486 [11] [8], [9] or [10], the processed ganoderma lucidum product obtained by the method of manufacturing [8], [9] or [7], or the processed ganoderma lucidum product of [11] Food and beverage, [13] Food and beverage with the above-mentioned [12] marked with anti-tumor effect, immune activation effect or anti-cancer effect, [14] Ganoderma treatment containing [6] or [7], Or the pharmaceutical product of the processed ganoderma lucidum of [11] above, and the pharmaceutical product of [I4] above that [I5] is an antitumor agent. '' According to the present invention, Ganoderma lucidum processed product or processed Ganoderma lucidum which has excellent extraction efficiency and industrially favorable anti-tumor effect is produced. Furthermore, according to the present invention, it is possible to provide a food or a medicine containing a Ganoderma lucidum treated product or a processed product of Ganoderma lucidum which is excellent in the aforementioned antitumor effect. [Embodiment] The Ganoderma lucidum used in the present invention is a fruiting body of Ganoderma lucidum (Fr.) Krast of polyporaceae. Ganoderma lucidum can also grow with the same species, according to temperature, humidity, luminosity, carbon dioxide concentration and other growth conditions, or according to the origin and system of the strain, it can cultivate fruit bodies (ganoderma lucidum) of different colors or shapes, classified by different colors There are types such as green, red, yellow, white, purple, and black, and they are classified into staghorn, oxhorn, yunzhi, meat and other types according to the shape. In the present invention, any of the above-mentioned ganoderma can be used, and a commercially available product called ganoderma or staghorn ganoderma can also be used as ganoderma. In the present invention, all the fruit bodies of Ganoderma lucidum can be used, or a part of the fruit bodies can be used (such as those that have been appropriately cut off) as 316979 200536486 • Beijing materials, and the above s usually means no water or organic solvents, etc. Treatment. In the present invention, the aforementioned ganoderma can be prevented from contacting water before the water vapor treatment is applied. 2. One aspect of the present invention is a person who processes Ganoderma lucidum with water vapor at 150 to 2 UTC to produce a Ganoderma lucidum treatment object. "In the present invention, the water vapor used for the treatment of ganoderma is preferably saturated water vapor from the point of workability and operability, but it is not limited to this. The processing conditions are as long as the water vapor temperature is 150i to 21 generations. It is not particularly limited. In the aspect of the present invention, it is particularly preferable that the temperature range is 170 to 21 ° (180 ° to 210 ° C). Since the water vapor temperature is 15G ° C, Increasing the effect will decrease the temperature and increase the effect of the aforementioned active ingredient to 2HTC, which is not ideal. The treatment time is not particularly limited so as not to hinder the object of the present invention, but it is 1 to 30 minutes. Limit.—In general, the higher the temperature of the water, the shorter the processing time; for example, if the temperature of the water is iron, the minutes are what we expect. It is particularly limited because of the concern about the influence of oxygen 4 ′ on the generation of organic acids or furfural due to oxidative decomposition, it is better to use a low oxygen concentration. For example, the gas concentration of / mL is what we expect. The aforementioned treatment can be performed at normal pressure. Proceed, but-generally It is said that it is pure under pressure. When it is performed under pressure, the pressure is not particularly limited. The pressure when using saturated water vapor as the water vapor is usually 03 316979 9 200536486 to 1.8 MPa. The water vapor treatment can be performed using a conventional treatment device. The treatment device is not particularly limited as long as it can perform water vapor treatment at 150 to 210 ° C. For example, a high-temperature and high-pressure reaction device manufactured by AKICO Corporation or Nisaka can be used. High-temperature wet heat treatment test equipment (HTS-25 / 140-8039) manufactured by Seisakusho Co., Ltd., Superheated steam generator (DPH GH20) manufactured by Seta Kosan Chemical Co., Ltd., etc. In the present invention, by The obtained Ganoderma lucidum processed material is further subjected to a conventional processing to produce a processed Ganoderma lucidum. For example, by processing the above-mentioned Ganoderma lucidum- 1) by cutting or powdering, 2) extracting with an aqueous solvent, 3) The extract solution obtained in the above 2) is further concentrated and refined or dried and powdered to produce processed Ganoderma lucidum. The treatment in any one of the above 1) to 3) can also be performed by a conventional method. ® Where the above 2) is used When manufacturing processed Ganoderma lucidum products, extraction operations can be performed by common methods as long as the extraction temperature, time, and equipment are appropriately selected. The aqueous solvents used as the extraction solvent in the above 2) treatment include aqueous solvents or water. In addition, it is also possible to use high-pressure greens to extract with hot water at, for example, 120 ° C. Therefore, a processed Ganoderma lucidum product is obtained as an extraction solution. In the case of processing the processed Ganoderma lucidum by using the process 3), for example, By removing the solvent of the extract obtained through the process of 2) above, it becomes a concentrated extract, or freeze drying or air drying can be used to make the extract 10 316979 200536486 The liquid can also be diluted with a solvent such as water and treated by 2) above.

本發明之一 $之加工品者。 壓水。 態樣用150至^(^的水萃取靈 本發明中靈芝萃取所用的水希望 芝以製造 是高溫高 —處理條件只要水的溫度在150至2HTC就沒有特 定。在本發明方面’前述溫度範圍中係以⑽至2 ^ •車乂仏。由於水的溫度不& 15〇。。時,抗腫瘤作用之活性成 -分的增大效果會降低,而高於21〇。〇時也會降低前述活性 ' 成分的增大效果,因此並不理想。 再者,前述處理中的氧濃度並沒有特別限定,由於氧 夕日可,因氧化分解而生成有機酸或糠醛等,會有對香味產 生影響的顧慮,因此以低氧濃度者為較佳。例如〇至i ^ / ml的氧濃度為吾人所期望者。 _、 剞述處理能在常壓下進行,但一般而言在加壓下進行 為較佳。於加壓下進行的情況下,加壓壓力並沒有特別限 定,加壓壓力通常為〇.3至1.8 MPa。 上述水處理可使用習知的處理裝置進行。處理裝置只 要可容許150至210°C之高溫高壓下的水萃取處理就沒有 特別限定,例如可使用AKICO公司製造的高溫高壓反應 裝置或日阪製作所(股)製造的高溫濕熱處理試驗裝置 (HTS-25/ 140-803 9),瀨田興產化工(股)製造的過熱蒸氣 發生裝置(DPH GH20)等。 316979 200536486 本發明能使用以上述用法,用高溫高壓的水所萃取之 萃取液作為靈芝加工品。 本發明能對如上述所得到的靈芝加工品進一步施加習 知的處理。例如可藉由移除萃取液的溶劑成為濃縮萃取 物,或者可用凍乾或風乾等手段藉由使前述萃取液乾燥成 為乾燥粉末品。再者,也可用水等溶劑加以稀釋。這些也 稱為靈芝加工品。 本發明之一態樣為用150至210°C的水蒸氣處理靈芝 修以製造靈芝處理物者。 . 像這樣所得到的靈芝處理品或靈芝加工品含有高含量 . 之已知具有抗腫瘤效果的水溶性-葡聚糖。舉例而言,相 對於在未處理品的情況下,無法從1 00 g的靈芝中萃取出 0· 1 g以下的水溶性/3-葡聚糖,進行本發明之水蒸氣處理或 高溫高壓水處理,每100 g的原料靈芝可提供0.5至5 g 的水溶性葡聚糖。 本發明之其他態樣亦為含有上述靈芝處理物或上述靈 •芝加工品的飲食品和醫藥品。這類飲食品和醫藥品係由上 述靈芝處理物或上述靈芝加工品使用習知手段製造。由於 上述靈芝處理物和上述靈芝加工品具有優異的安全性,因 此通常不需要用以獲得安全性等特別處理。本發明之飲食 品與醫藥品中,上述靈芝處理物和上述靈芝加工品的配合 量可考慮其效果,添加時製品的香味、色調等而適當地決 定其配合量。然而,配合量的較佳具體範圍例示以上述靈 芝處理物或上述靈芝加工品換算為乾燥重量計,對於飲食 316979 200536486 ‘品或醫藥品全體而言,通常希望在〇 〇1至99 9質量%,較 佳為0.01至99.5質量。/。的範圍。 上述I人良。口可列舉糖、糖鍵、口香糖、酸乳、冰漠淋、 布丁、果;東、水羊羹、酒精飲料、茶飲料、吻。非飲料、果 汁、果汁飲料、碳酸飲料、;青涼飲料水、牛乳、乳清飲料、 乳酸菌飲料等各種飲食品。 、上述飫5 °σ,上述靈芝處理物或上述靈芝加工品,及 視需要配合的各種添加劑能根據常用方法製造。必要時所 配合的添加劑列舉例如葡萄糖、果糖、嚴糖、麥芽糖、山 梨糖醇、蛇菊苔、甜茶脊(rubus〇side)、玉米㈣、乳糖、 榉棣酸、酒石酸、蘋果酸、琥珀酸、乳酸、L-抗壞血酸、 mi m分、異抗壞血酸納(s〇dmm巧如加⑷甘油、 1甘油知肪馱、聚甘油脂肪酸酯、蔗糖脂肪酸酯、 “水山梨醇脂肪酸g旨、丙二醇脂肪酸3旨、阿拉伯樹膠、海 珠膠(carrageenan)、酪蛋白、明膠、果膠、瓊脂、维生素b 類、於鹼醯胺、泛酸鈣、胺基酸類、舞鹽類、色素、香料、 防腐劑等平常使用作為食品原料者。 、、=者’上述飲食品也可為健康食品。健康食品的形狀 有特別限定’可為製成顆粒、膠囊、藥丸、片劑 μ、萃取物、糊狀物、飲料等形狀者。或者可如革類, 2用熱水等萃取的形態。本發明中,依照常用方法,"能 衣以適量含有上述靈芝處理物或上述靈 。 夕从由人 < 刀口工口口作為目的 二良品。更具體而言’例如依照常用方法能適當配人 上迷致芝處理物或上述靈芝加工品,以及所期望的植物: 316979 13 200536486 等油脂類,含水羊毛脂或蜂蠟等蠟類,烴類,脂肪酸,高 級醇類,酯類,各種色素,香料,維生素類,植物、動物 抽出成分,抗氧化劑,防腐、殺菌劑等平常使用作為健康 食品原料者而得到健康食品。 本發明之飲食品能賦予已知為β-葡聚糖之效能的作 用,例如具有抗腫瘤作用、免疫活化作用或抗癌作用的 標示者。標示位置列舉有容器或其中所附加的說明書等。 表示方法包含印刷、打印、封印等,但不限定於此。 φ 再者,本發明之飲食品從上述任一靈芝處理物和靈芝 . 加工品都具有良好的抗腫瘤作用來看,適合用來作為所謂 . 的健康食品,作為保健機能食品。特別適合用來作為具有 抗腫瘤作用的飲食品。 本發明之醫藥品能配合上述靈芝處理物或上述靈芝加 工品及視需要的各種添加劑,進而適量含有靈芝加工品, 調製成各種劑形的醫藥品。 上述醫藥品的形態列舉例如錠劑、膠囊劑、散劑、糖 ®漿劑、萃取物劑等經口醫藥品,或軟膏、眼軟膏、洗劑、 乳劑、貼劑、栓劑、點眼藥、點鼻藥、注射劑等非經口醫 藥品。這些醫藥品可使用上述靈芝處理物或上述靈芝加工 品及視需要的各種添加劑依照常用方法製造。所用的添加 劑能使用眾所周知者,該添加劑實例可列舉澱粉、乳糖、 白糖、甘露糖醇、羧曱基纖維素、玉米澱粉、無機鹽等固 態載體;蒸餾水、生理食鹽水、葡萄糖水溶液、乙醇等醇 類、丙二醇、聚乙二醇等液體載體;各種動植物油、白凡 14 316979 200536486 士林、石蠟、蠟類等油性載體等。 上述靈芝處理物和上述靈芝加工品的每日使用量、投 ‘ 與量沒有特別限制,舉例而言以乾燥重量換算可為0.01 mg 至1 00 g,但特別是在期待以經口方式獲得顯著抗腫瘤作 用的情況下,舉例而言以乾燥重量換算為0.1 g至20 g為 較佳。 本發明之飲食品(特別是健康食品)及醫藥品也可與其 他具有抗腫瘤作用的飲食品、健康食品或醫藥品的原料, 鲁例如巴西蘑菇(Agaricus)、舞菇、桑黃等簟類,含有/3-葡聚 • 糖等抗癌多醣類的微生物或其酿酵產物,多醣體(Krestin) ^ 等醫藥品等併用。 再者,於使用本發明之飲食品或醫藥品、添加劑的情 況下,其混合比率可按照目的適當地設定,並沒有特別限 定。 本發明之醫藥品從上述任一靈芝處理物和靈芝加工品 都具有良好的抗腫瘤作用來看,適合用來作為抗腫瘤劑。 ®再者,從經口服用時也有優異的安全性來看,可適合用來 作為經口醫藥品。 實施例 (實施例1-1) 使用鹿角靈芝(市售品,中國山東省產)作為原料。並 且於高溫高壓處理中使用AKICO公司製造的高溫高壓反 應裝置。 15 316979 200536486 、 於sus 3 1 6合金製的耐熱耐壓容器(400 ml)中裝入以 氛氣冒泡除去溶氧的4〇 mi水。於SUS 3 16合金製的200 mi 監中裝入切斷成1 cm片的鹿角靈芝丨〇 g ,將這些靈芝以 不接觸到水的方式設置在sus 316合金製的耐熱耐壓容器 中。藉由在約5秒過程中送入氮氣置換容器内的空氣後, 於150。(:的飽和水蒸氣,加壓壓力為〇 38 ㈣^ml的條件下,進行水蒸氣處理$分鐘。接著,使 於反應容器變成贼時打開容器,$出鹿角靈 所得鹿角靈芝處理物裝入耐壓瓶妙 水,於]2〗Τ' 7 π八力’、、'、後衣入1L的 、1C,3〇刀在里的條件下進 得一到鹿角靈芝萃取物(靈芝加工品)。,取(-堡金卒取), (貫施例1 -2) 水蒸氣,0.66 1 -1同樣地實 除了水蒸氣處理條件為17〇t MPa,氧濃产為pjQs / 、匕 平辰度為0.95仰/⑹以外,鱼者One of the invention's processed products. Press water. It is extracted with water of 150 to ^ (^) in the present invention. The water used for the extraction of ganoderma in the present invention is expected to be made at high temperature and high temperature. The processing conditions are not specific as long as the temperature of the water is 150 to 2 HTC. The middle range is ⑽ to 2 ^ • car 乂 仏. As the temperature of the water is not & 15 0, the effect of increasing the anti-tumor activity component-min will be reduced, and it will also be higher than 20.0. The effect of reducing the increase of the aforementioned active ingredients is not ideal. Furthermore, the oxygen concentration in the aforementioned treatment is not particularly limited. Since oxygen can be used, organic acids or furfural can be generated due to oxidative decomposition, which can cause aroma generation. Concerns about the impact, so it is better to have a low oxygen concentration. For example, the oxygen concentration of 0 to i ^ / ml is what we expect. _, The treatment can be performed under normal pressure, but generally under pressure The process is preferably performed. When the process is performed under pressure, the pressurization pressure is not particularly limited, and the pressurization pressure is usually 0.3 to 1.8 MPa. The above-mentioned water treatment can be performed using a conventional treatment device. Allows high temperatures from 150 to 210 ° C The water extraction treatment under high temperature and high pressure is not particularly limited. For example, a high temperature and high pressure reaction device manufactured by AKICO or a high temperature wet heat treatment test device (HTS-25 / 140-803 9) manufactured by Nisaka Manufacturing Co., Ltd. can be used. Seta Superheated steam generator (DPH GH20), etc. manufactured by Xingchan Chemical Industry Co., Ltd. 316979 200536486 The present invention can use the extract solution extracted with high temperature and high pressure water as the processed product of Ganoderma lucidum. The obtained processed Ganoderma lucidum is further subjected to a conventional treatment. For example, the solvent of the extract solution can be removed to become a concentrated extract, or the aforementioned extract solution can be dried into a dry powder product by means of freeze-drying or air-drying. Furthermore, It can also be diluted with solvents such as water. These are also known as processed ganoderma. One aspect of the present invention is to treat ganoderma with water vapor at 150 to 210 ° C to produce ganoderma processed products. Or ganoderma processed products contain high levels of water-soluble glucans known to have antitumor effects. For example, It is impossible to extract water-soluble / 3-glucan less than 0.1 g from 100 g of ganoderma, and the water vapor treatment or high-temperature and high-pressure water treatment of the present invention can be performed. Each 100 g of raw ganoderma can provide 0.5 to 5 g of water-soluble dextran. Other aspects of the present invention are also foods and medicines containing the above-mentioned ganoderma processed products or the above-mentioned processed products of ganoderma lucidum. The processed ganoderma lucidum is manufactured by conventional means. Since the processed ganoderma and processed ganoderma have excellent safety, it is generally not necessary to use special treatment for obtaining safety and the like. In the food and drink and medicine of the present invention, The blending amount of the processed ganoderma and the processed processed ganoderma can be considered in consideration of its effect, and the blending amount of the product can be appropriately determined when adding the flavor and color of the product. However, a preferable specific range of the compounding amount is exemplified by the conversion of the above-mentioned ganoderma processed product or the processed ganoderma lucidum to dry weight. Generally, it is desired that it is from 0.001 to 99 9% by mass for food and drink 316979 200536486 'or pharmaceutical products. , Preferably 0.01 to 99.5 mass. /. Range. I'm good. Examples of the mouth include sugar, sugar bond, chewing gum, yogurt, ice desert, pudding, fruit; east, water goat, alcoholic beverage, tea beverage, kiss. Non-beverages, fruit juices, fruit juice drinks, carbonated beverages, cool drinks, milk, whey drinks, lactic acid bacteria drinks and other food and beverage products. The above 饫 5 ° σ, the processed ganoderma or processed ganoderma, and various additives as required can be manufactured according to a common method. Examples of additives to be blended when necessary include, for example, glucose, fructose, sucrose, maltose, sorbitol, stevia rebaudiana, rubusside, corn mash, lactose, bezel acid, tartaric acid, malic acid, succinic acid, Lactic acid, L-ascorbic acid, mim, sodium erythorbic acid (sodmm) such as glycerol, glycerol, glycerol, polyglycerol fatty acid ester, sucrose fatty acid ester, "sorbitan fatty acid g, propylene glycol fatty acid 3 purposes, gum arabic, carrageenan, casein, gelatin, pectin, agar, vitamin b, alkalamine, calcium pantothenate, amino acids, dance salts, pigments, spices, preservatives, etc. Those who use it as food ingredients. The above-mentioned foods and drinks can also be health foods. The shape of health foods is particularly limited. They can be made into granules, capsules, pills, tablets μ, extracts, pastes, and beverages. Or other shapes, such as leather, which can be extracted with hot water, etc. In the present invention, according to a common method, "Neng Yi" contains the above-mentioned ganoderma treatment or the above-mentioned spirit in an appropriate amount. lt; The knife edge is the second best product for the purpose. More specifically, 'For example, according to a common method, it can be appropriately matched with the processed product of ganoderma lucidum or the processed product of the above-mentioned ganoderma, and the desired plant: 316979 13 200536486, such as oils and fats, containing water Waxes such as lanolin or beeswax, hydrocarbons, fatty acids, higher alcohols, esters, various pigments, spices, vitamins, plant and animal extracts, antioxidants, preservatives, fungicides, etc. are commonly used as raw materials for health foods. The health food is obtained. The food and drink of the present invention can impart the effect known as β-glucan, for example, a marker having an antitumor effect, an immune activation effect, or an anticancer effect. The label position is listed on a container or attached to it The instructions include printing, printing, sealing, etc., but are not limited to this. Φ Furthermore, the food and beverage of the present invention has good antitumor effects from any of the above-mentioned ganoderma treatment and ganoderma. Processed products , Suitable for use as so-called health food, as a health food, especially suitable for use as an anti-tumor agent Food. The pharmaceutical product of the present invention can be formulated with the above-mentioned ganoderma lucidum processed product or the above-mentioned ganoderma processed product and various additives as required, and further contains a processed ganoderma lucidum product in an appropriate amount to prepare various pharmaceutical forms. Examples of the above-mentioned pharmaceutical products include lozenges , Capsules, powders, sugars, syrups, extracts and other oral medicines, or ointments, eye ointments, lotions, emulsions, patches, suppositories, eye drops, nose drops, injections and other non-oral medicines These medicines can be manufactured according to common methods by using the above-mentioned ganoderma processed products or the above-mentioned ganoderma processed products and various additives as required. The additives used can be well-known. Examples of the additives include starch, lactose, white sugar, mannitol, Carboxymethyl cellulose, corn starch, inorganic salts and other solid carriers; distilled water, physiological saline, glucose aqueous solution, alcohols such as ethanol, propylene glycol, polyethylene glycol and other liquid carriers; various animal and vegetable oils, Bai Fan 14 316979 200536486 Shihlin , Paraffin, wax and other oily carriers. There are no particular restrictions on the daily use, dosage, and amount of the Ganoderma lucidum processed product and the processed Ganoderma lucidum processed product. For example, it can be 0.01 mg to 100 g in terms of dry weight. In the case of an antitumor effect, for example, it is preferably 0.1 g to 20 g in terms of dry weight. The food and drink (especially health food) and medicines of the present invention can also be used as raw materials for other foods, health foods or medicines with anti-tumor effects, such as Agaricus, Maitake, Morus alba, etc. , Microbes containing anti-cancer polysaccharides such as / 3-glucose and sugar or their fermented products, polysaccharides (Krestin) ^ and other pharmaceutical products. When using the food, drink, medicine or additive of the present invention, the mixing ratio can be appropriately set according to the purpose, and is not particularly limited. The pharmaceutical product of the present invention is suitable for use as an antitumor agent in view of the good antitumor effect of any of the above-mentioned ganoderma treatment products and processed ganoderma products. ® Furthermore, it is suitable for oral medicine because of its excellent safety when used orally. Examples (Example 1-1) Antler ganoderma (commercial product, produced in Shandong Province, China) was used as a raw material. A high-temperature and high-pressure reactor manufactured by AKICO is used for high-temperature and high-pressure processing. 15 316979 200536486. A sus 3 1 6 alloy heat-resistant and pressure-resistant container (400 ml) was filled with 40 mi of water which was bubbled with an atmosphere to remove dissolved oxygen. Into a 200 mi monitor made of SUS 3 16 alloy, staghorn ganoderma lucidum cut into 1 cm pieces was placed, and these ganoderma were placed in a heat-resistant and pressure-resistant container made of sus 316 alloy without contact with water. The air in the container was replaced by nitrogen in the course of about 5 seconds, then at 150. (: Saturated water vapor, pressurized at a pressure of 038 ㈣ ml, water vapor treatment is performed for $ minutes. Then, when the reaction container becomes a thief, the container is opened, and the antlers-ganoderma lucidum treatment product obtained from the antlers is loaded Pressure-resistant bottle of wonderful water, in [2] T '7 π Eight Force' ,, ', 1L, 1C, 30 knives into the back of the staghorn ganoderma lucidum extract (ganoderma processed product) , Take (-Pao Jinzu take), (Performance Example 1-2) Water vapor, 0.66 1 -1 Similarly, except that the water vapor treatment conditions are 17〇t MPa, and the oxygen concentration is pjQs /, Ding Pingchen. Degrees other than 0.95 Yang / ⑹, fish

,得到鹿角靈芝萃取物(靈芝加I品;、。貝" (實施例1«3) 除了水蒸氣處理條件為180。 他,氧;農度為0.95 ^ml以外,盘水蒸氣,U5 施得到鹿角靈芝萃取物(靈…例Η同樣地實 / ―1-' οσ ) 〇 (貫施例1-4) 除了水蒸氣處理條件為 心,氧濃度為〇 95仰/ C的飽和水蒸氣,Μ 施得到鹿角靈芝萃取物(靈芝力丄,施例1-1同樣地實 316979 200536486 (實施例-5) 除了水条氣處理條件為210°C的飽和水蒸氣,18 ΜΡ^氧濃度為G·95批/如以外,與實施例Μ同樣地實 她得到鹿角靈芝萃取物(靈芝加工品)。 (比較例1-1) 除了水蒸氣處理條件為22(rc的飽和水墓氣,22To obtain staghorn ganoderma lucidum extract (ganoderma lucidum plus I product ;, shellfish) (Example 1 «3) except that the water vapor treatment conditions are 180. He, oxygen; agricultural degree is 0.95 ^ ml, water vapor, U5 application Antlers Ganoderma lucidum extract was obtained (spirit ... Example Η same as ―1- 'οσ) 〇 (consistent Example 1-4) Except for water vapor treatment conditions, the oxygen concentration was 095 Yang / C saturated water vapor, An antler extract of Ganoderma lucidum (Ganoderma Lucidum, Example 1-1 was performed in the same manner as 316979 200536486 (Example-5) except that the water stripe was treated at 210 ° C in saturated water vapor, and the concentration of 18 MPa was G. · 95 batches / except, in the same manner as in Example M, she obtained antlers ganoderma lucidum extract (ganoderma lucidum processed product). (Comparative Example 1-1) Except for water vapor treatment conditions of 22 (rc saturated water grave gas, 22

Mpa,氧濃度為〇 95 / "g/ml以外,與貫施例Μ同樣地實 施得到鹿角靈芝萃取物。 ^只 (比較例1-2) 除乂水蒸氣處理條件為250。〇的飽和水蒸氣,4·5 a虱,辰度為〇 95处/邱以外,與實施例[I 知得到鹿角靈芝萃取物。 Ά (比較例1-3) 除了水蒸氣處理條件為30(rc的飽和水蒸氣,9 ι Pa ’氧濃度為0.95 yg/mi以外, 她侍到鹿角靈芝萃取物。 月、 (比較例1-4) 壯不進行水蒸氣處理,將鹿角靈芝裝入耐壓瓶中, 二二的:卜於121。。,3。分鐘的條件下進行萃取(高壓 蒼个取),得到鹿角靈芝萃取物。 (4驗例1)用高溫高壓水蒸氣處理所 瘤活性 之加工m的彳几腫 評估上述實施例w、實施例i_3幻_5及比較例U 至1 -4所得鹿角靈芝萃取物的抗腫瘤作用。 316979 17 200536486 在C3H鼠(日本Charles River公司)的鼠頸部皮下接種 2x1 06個細胞的MM46乳癌細胞,使用該鼠(以下稱為 MM46罹癌鼠)作為被驗體。 皮下接種10、12、14天後,分別將上述實施例1-1、 貫施例1-3至I-5及比較例1-2至1-4所得鹿角靈芝萃取物 的康乾品溶解在生理食鹽水中以每1隻鼠250仰的方式投 與在腹腔内。再者,使用僅投與等量生理食鹽水的MM46 羅癌乳作為對照組。皮下接種28天後摘出腫瘤測定重量, =對照鼠的腫瘤重量作為1〇〇%時,比較每隻鼠的腫瘤重 里。測定結果示於表1。Except for Mpa and oxygen concentration of 0.95 / g / ml, staghorn lingzhi extract was obtained in the same manner as in Example M. ^ Only (Comparative Example 1-2) The water-removal treatment conditions were 250. Saturated water vapor of 〇, 4 · 5 a lice, the degree of 辰 95 places / Qiu, and Example [I] to obtain antlers Ganoderma lucidum extract. Ά (Comparative Example 1-3) In addition to the water vapor treatment conditions of 30 (rc of saturated water vapor, 9 Pa Pa 'oxygen concentration of 0.95 yg / mi, she served antlers Ganoderma lucidum extract. Month, (Comparative Example 1- 4) Without water vapor treatment, put staghorn ganoderma into a pressure-resistant bottle, 22: bu at 121 ..., 3 minutes of extraction (high pressure Cang take) to obtain staghorn ganoderma extract. (4 Test Example 1) Evaluation of the antitumor activity of the antlers ganoderma lucidum extract obtained in the above-mentioned Examples w, Example i_3, and P_5, and Comparative Examples U to 1-4, was evaluated by treating the tumours of the processed tumors with high temperature and high pressure water vapor. 316979 17 200536486 C3H mice (Charles River, Japan) were subcutaneously inoculated with 2 × 10 06 cells of MM46 breast cancer cells, and the mice (hereinafter referred to as MM46 cancer-bearing mice) were used as subjects. Subcutaneous inoculation10. After 12 and 14 days, the dried dried antlers of Ganoderma lucidum extract obtained in the above Examples 1-1, Examples 1-3 to I-5, and Comparative Examples 1-2 to 1-4 were dissolved in physiological saline at The rats were administered in the abdominal cavity in a 250-row manner. Furthermore, MM administered with only the same amount of physiological saline was used. 46 Luo cancer milk was used as a control group. The tumor weight was determined 28 days after subcutaneous inoculation, and the tumor weight of each mouse was compared when the tumor weight of the control mice was 100%. The measurement results are shown in Table 1.

的\ I ’與投與比較例丨-4之鹿角靈芝萃取物時 物二=:,可判別出投與實施例之鹿角靈芝萃取 物日T的抗腫瘤活性較黑 萃取物時的抗腫瘤活性相:與投與實施例之鹿角靈芝 比較例1-3之鹿角靈芝X :判別出投與比較例丨-2和 工之个取物時的抗腫瘤活性較低。此可 316979 18 200536486 認為係活性成分分解的進行所致。 (實施例2-1) ‘ 使用鹿角靈芝(市售品,中國山東省產)作為原料。並 且於高溫高壓處理中使用KICO公司製造的高溫高壓反應 裝置。 於SUS 316合金製的耐熱耐壓容器(400 ml)中裝入以 氮氣冒泡除去溶氧至氧濃度為0.95 /ig/ml以下的230 ml 水。於SUS 316合金製的200 ml籃中裝入切斷成1 cm片 籲的鹿角靈芝l〇g,將這些靈芝設置在SUS 3 16合金製的耐 . 熱耐壓容器中。藉由在約5秒過程中送入氮氣置換容器内 的空氣後,保持在150°C的溫度,0.3 8 MPa的壓力下處理 5分鐘。接著,使容器冷卻,於反應容器變成80°C時打開 容器,回收鹿角靈芝萃取物。將此萃取物康乾得到靈芝加 工品(凍乾品)。 (實施例2-2) 除了處理條件為180°C的飽和水蒸氣,0.85 MPa以 春外,與實施例2-1同樣地實施得到鹿角靈芝萃取物。將此 萃取物凍乾得到靈芝加工品(凍乾品)。 (實施例2-3) 除了處理條件為210°C的飽和水蒸氣,1.4 MPa以外, 與實施例2-1同樣地實施得到鹿角靈芝萃取物。將此萃取 物凍乾得到靈芝加工品(凍乾品)。 (試驗例2)用高溫高壓水萃取所得靈芝加工品的抗腫瘤活 性 19 316979 200536486 至2 -〇所得靈芝加工品的抗腫瘤 *"平估上述貫施例2 -1 作用。 使用試驗例i所示的MM46羅癌鼠作為被驗體。 皮下接種1 0、〗2、14天後,分別將上述實施例2_丨至 2-3所得靈芝加工品溶解在生理食鹽水中以每^隻鼠 处的方式投與在腹腔内。再者,使用僅投與等量生理食鹽 ^的^M46惟癌鼠作為對照組。皮T接種28天後摘出腫 瘤測疋重量’以對照鼠的腫瘤重量作為100%時,比較每 隻鼠的腫瘤重量。測定結果示於表2。 ^果ίί較例1-4 (未處理品)比較,可判別出本發明 之任種莖芝加工品均具有優異的抗腫瘤作用。 【表2]\ I 'and administration of the antler ganoderma lucidum extract of Comparative Example 丨 -4 when the second substance = :, can determine the antitumor activity of the antler ganoderma lucidum extract of Example T when administered, compared with the antitumor activity of the black extract Phase: Antler ganoderma lucidum of comparative example 1-3 of the administration example of antler ganoderma lucidum X: The antitumor activity was low when discriminating the administration of comparative example 丨 -2 and one of the samples. This can be attributed to the progress of decomposition of the active ingredient. (Example 2-1) ‘Antlers Ganoderma (commercial product, produced in Shandong Province, China) was used as a raw material. A high-temperature and high-pressure reactor manufactured by KICO was used for high-temperature and high-pressure processing. A heat-resistant and pressure-resistant container (400 ml) made of SUS 316 alloy was charged with 230 ml of water to remove dissolved oxygen to an oxygen concentration of 0.95 / ig / ml or less by bubbling nitrogen. In a 200 ml basket made of SUS 316 alloy, 10 g of staghorn ganoderma lucidum cut into 1 cm pieces was placed, and these ganoderma were placed in a SUS 3 16 alloy heat-resistant and pressure-resistant container. After the air in the container was replaced with nitrogen gas for about 5 seconds, the temperature was maintained at 150 ° C and the pressure was treated at 0.3 8 MPa for 5 minutes. Next, the container was cooled, and when the reaction container became 80 ° C, the container was opened, and the staghorn lingzhi extract was recovered. This extract was dried to obtain Ganoderma lucidum processed product (lyophilized product). (Example 2-2) A staghorn lucid ganoderma extract was obtained in the same manner as in Example 2-1, except that the processing conditions were saturated water vapor at 180 ° C and spring at 0.85 MPa. This extract was lyophilized to obtain a processed Ganoderma lucidum (lyophilized product). (Example 2-3) A staghorn lucid ganoderma extract was obtained in the same manner as in Example 2-1, except that the processing conditions were saturated water vapor at 210 ° C. and 1.4 MPa. This extract was lyophilized to obtain a processed Ganoderma lucidum (lyophilized product). (Experimental Example 2) Antitumor activity of Ganoderma lucidum processed product obtained by extraction with high temperature and high pressure water 19 316979 200536486 to 2-0 Antitumor activity of Ganoderma lucidum processed product * " Evaluation of the effect of the above-mentioned Example 2 -1. As the subject, a MM46 Luo cancer mouse shown in Test Example i was used. After 10, 2, and 14 days of subcutaneous inoculation, the processed Ganoderma lucidum products obtained in the above Examples 2 to 2-3 were dissolved in a physiological saline solution and administered to each abdominal cavity. Furthermore, ^ M46 cancer-free mice administered only with the same amount of physiological salt were used as a control group. Tumors were removed 28 days after skin T inoculation. The tumor weight was measured and the tumor weight of the control mice was taken as 100%, and the tumor weight of each mouse was compared. The measurement results are shown in Table 2. ^ Compared to Comparative Examples 1-4 (untreated product), it can be discriminated that any of the processed stem lenticular products of the present invention has an excellent antitumor effect. 【Table 2]

(試驗例3)靈芝加工品的萃取率 芝萃及比較例^1至〜 鹿角靈芝總4:比:取率為表示鹿角靈芝萃取物重量對 圖。可判別出:=的質量百分率。測定結果示於第1 比較例心二萃二至。1…何一個萃取率物 316979 20 200536486 ^ 4)巫之加工品之水溶性葡聚糖的溶解析出 f溶性^葡聚糖已知為抗腫瘤作用的成分之一。因 …語—析抗腫瘤效果特別強的實施例1 -4和實施例2-2所 付靈芝二工品之水溶性葡聚糖的溶解析出量。以比較例 所仔鹿角靈芝萃取物之0一葡聚糖的溶解 象而分析。 Τ _刀析杈口口係使用1 g鹿角靈芝萃取物溶解於40 ml的 者,*照常用方法以酵素法分析。換言t,使分析 樣口口於0.08 IV[的磷酸緩衝劑中與Termamyl⑱反應,用 敕/合液凋整至pH 7·5,以蛋白酶反應。之後用鹽酸調 正欠至PH 4.3,以澱粉轉葡糖苷酶反應。之後添加*倍量的 95,乙得到沈殿物(粗w聚糖劃分)。將此沈殿物用 醇接著用丙酮洗淨,於添加硫酸和水的沸騰浴中 力尺刀解中和所得產物,過濾後用葡萄糖氧化酶法(使用 和光=Glucose CII Wak〇)定量濾液中的葡萄糖。由i〇〇 g 鹿角里之付到之萃取物中所含的水溶性^一葡聚糖含量示 於第2圖。 從試驗例4可清楚判別出用實施例丨_4和實施例2_2 的方法所得靈芝加工品(靈芝萃取物)係溶解析出較多的水 冷=/3-葡聚糖。特別如實施M j _4所示,可判別出用飽和 水瘵氣處理靈芝後的熱水萃取法能有效地溶解析出水溶性 葡聚糖。 根據試驗例1至4,可判別出經由用15〇至21(Γ(:的水 或水蒸氣處理靈芝,不僅提高萃取率,而且還能有效溶解 316979 200536486 析出水溶性/3-葡聚糖,得到增強抗腫瘤作用的靈芝加工 品° —(實施例3) 於高溫水蒸氣處理中使用高溫濕熱處理試驗裝置(曰 阪製作所(股)製造:HTS-25/ 140-8039)、蒸氣鍋爐(三浦 工業(股)製造:FH—100)。於SUS 316合金製的12L籃中 裝入切斷成1 cm片之實施例1-1所使用的鹿角靈芝1.5 kg,將此籃設置在SUS 316合金製的耐熱耐壓容器(30 L) 鲁内,加以密閉。於約1秒過程中送入使用經由脫氧裝置(三 • 浦工業(股)製造:DOR-1000P)脫氧的水(氧濃度為0.3 "g _ / ml)所產生的高溫高壓飽和蒸氣置換容器内的空氣後,在 200°C,加壓壓力為1.4 MPa的高溫高壓狀態下保持300 秒鐘。脫氣後,於反應容器變成80°C以下時打開容器。接 著,將上述所得鹿角靈芝的水蒸氣處理物添加24 L水,進 行2次121°C,30分鐘的萃取(高壓蒼萃取)。將所得萃取 物凍乾,得到鹿角靈芝乾燥粉末。 ® (試驗例5)鹿角靈芝乾燥粉末透過經口攝取的抗腫瘤效果 在鼠、大鼠用標準飼料AIN-93M(〇riental酵母工業(股) 製造)中,分別混合0.156質量%、0.625質量%、2.5質量 %之比率的實施例2所得鹿角靈芝乾燥粉末,得到3種混 合飼料(以下分別稱為0.156%鹿角靈芝食物、0.625%鹿角 靈芝食物、2.5%鹿角靈芝食物)。 也將未處理的鹿角靈芝(市售品,中國山東省產)粉 碎,使鹿角靈芝粉末以2.5%的比率混合於鼠、大鼠用標準 316979 200536486 飼料 AIN-93M(〇iieiital 酵母 (以下稱為2 · 5 %對照食物)作為 述调製的3種鹿角靈芝食物和 工品探討抗腫瘤效果如下。 工業(股)製造)中調製成飼料 對照。藉由自由攝取使用上 2.5%對照食物的鹿角靈芝加 將ddY鼠(日本SLC (股》分成$組(每1組1〇隻),使 ddY鼠分別僅自由攝取上述調製的3種鹿角靈芝食物、 2.5%對照食物及鼠、大鼠用標準飼料AIN一93M (以下稱為 對知、組食物)。經過1週的飼育後,於ddY鼠胸部皮下接 種lxlO6個細胞的SarC〇mai80肉腫細胞,作為Sarc〇mal8〇 罹癌鼠。繼續分別給予上述調製的3種鹿角靈芝食物、2 5% 對J3、?、食物及對卩?、組食物以飼育Sarcoma 1 80羅癌鼠。皮下接 種1 8天後摘出腫瘤測定其重量,以對照鼠的腫瘤重量作為 1 00%時,比較每隻鼠的腫瘤重量。測定結果示於表3。 【表3】 腫瘤重量(對照組的%) 0.156%鹿角靈芝食物 62.7 0.625%鹿角靈芝食物 62.1 2.5%鹿角靈芝食物 46 — 2.5%對照食物 75T5 ^ 對照組 Γόο ^ 從表3來看,於3種鹿角靈芝食物的情況下,抗腫瘤 活性隨濃度變化而增強。再者’攝取3種鹿角靈芝食物曰卞 的抗腫瘤活性顯示比在2 · 5 %對照食物、對照組食物日寺t 強0 316979 23 200536486 豕乂上可判別出本發明之靈芝加1品透過經口服用 也比未處理靈芝得到更高的抗腫瘤活性。 (試驗例6)高溫高麼水蒸氣處理鹿角靈芝透過經口攝取的 抗腫瘤效果 只知例M所用的鹿角靈芝與實施例3 (水蒸氣處理條 ^:、2峨’加_力為h4MPa,5分鐘)同樣地進行高溫 问堡水洛氣處理,不彳隹^ 古厭 +進仃问壓釜卒取,乾燥、粉碎後,以 0.625貝里%的比率混合於鼠、大鼠用標準飼料 AIN - 93M(〇riental酵母工業(股)製造)中調製成鹿角靈芝 食物(以下稱為0·625%鹿角靈芝食物)。使鹿角靈芝(市售 品,中國山東省產)粉碎的鹿角靈芝粉末以2.5%的比率混 合於鼠、大鼠用標準飼料AIN—93M(〇riental酵母工業(股) 製造)中也調製成飼料(以下稱為25%對照食物)作為對照。 使用攻些食物探討抗腫瘤效果如下。將C3h鼠(日本(Experimental example 3) Extraction rate of processed Ganoderma lucidum extract and comparative examples ^ 1 to ~ staghorn ganoderma total 4: ratio: The yield is a graph showing the weight of staghorn ganoderma extract. It can be discriminated: = mass percentage of =. The measurement results are shown in the first comparative example. 1 ... what is the extraction rate 316979 20 200536486 ^ 4) Soluble glucan from Witch ’s processed products f-soluble glucan is known as one of the antitumor ingredients. The reason is that the dissolving amount of the water-soluble dextran of the Ganoderma lucidum second-hand product of Examples 1-4 and 2-2, which are particularly strong in antitumor effect, is analyzed. The dissolution of the 0-glucan from the extract of Ganoderma lucidum in the comparative example was analyzed. Τ _ knife analysis mouth mouth is using 1 g of antlers Ganoderma lucidum extract dissolved in 40 ml, * analysis by enzyme method according to common methods. In other words, the analysis sample port was reacted with Termamyl (R) in a phosphate buffer of 0.08 IV [, and then adjusted to pH 7 · 5 with a hydrazone / syringe and reacted with a protease. It was then adjusted to pH 4.3 with hydrochloric acid and reacted with starch transglucosidase. After adding * times the amount of 95, B to obtain Shen Dianwu (crude glycan division). This Shen Dianwu was washed with alcohol followed by acetone, neutralized with a force ruler in a boiling bath containing sulfuric acid and water, and filtered. The amount in the filtrate was quantified by the glucose oxidase method (using Wako = Glucose CII Wak〇). glucose. The content of water-soluble ^ -glucan contained in the extract obtained from 100 g of antlers is shown in FIG. 2. From Test Example 4, it can be clearly discriminated that the processed Ganoderma lucidum (Ganoderma lucidum extract) obtained by the method of Example 丨 _4 and Example 2_2 yields more water-cooled = / 3-glucan. In particular, as shown in the implementation of Mj_4, it can be judged that the hot water extraction method after treating Ganoderma with saturated water radon gas can effectively dissolve and dissolve water-soluble glucan. According to Test Examples 1 to 4, it can be discriminated that by treating Ganoderma lucidum with water or steam of 150 to 21 (Γ (:), not only can the extraction rate be improved, but also it can effectively dissolve 316979 200536486 and precipitate water-soluble / 3-glucan. Ganoderma processed product with enhanced anti-tumor effect ° — (Example 3) A high-temperature wet heat treatment test device (HTS-25 / 140-8039 manufactured by Hansaka Manufacturing Co., Ltd.) was used for high-temperature water vapor treatment, and a steam boiler (Miura Industrial (stock) manufacturing: FH-100). A 12L basket made of SUS 316 alloy was loaded with 1.5 kg of staghorn lingzhi used in Example 1-1 cut into 1 cm pieces. This basket was set on SUS 316 alloy A heat-resistant and pressure-resistant container (30 L) made of aluminum was sealed, and it was fed into the water (oxygen concentration of 0.3) using a deoxidizer (DOR-1000P, manufactured by Miura Industrial Co., Ltd .: DOR-1000P) in about 1 second. " g _ / ml) after replacing the air in the container with high-temperature, high-pressure saturated steam, and maintained at 200 ° C and a pressure of 1.4 MPa for 300 seconds. After degassing, the reaction container became Open the container below 80 ° C. Next, deer Ganoderma lucidum treated with 24 L of water was added twice at 121 ° C for 30 minutes (high pressure Cang extraction). The obtained extract was lyophilized to obtain dried staghorn ganoderma lucidum powder. ® (Test Example 5) dried staghorn ganoderma lucidum Antitumor effect of oral ingestion of powder In an example of a rat and rat standard feed AIN-93M (manufactured by Riental Yeast Industry Co., Ltd.), examples were mixed at a ratio of 0.156% by mass, 0.625% by mass, and 2.5% by mass, respectively. 2 The obtained antlers ganoderma lucidum dry powder was obtained into 3 kinds of mixed feeds (hereinafter referred to as 0.156% antler ganoderma lucidum food, 0.625% antler ganoderma lucidum food, 2.5% antler ganoderma lucidum food). Untreated antler ganoderma lucidum (commercial product, Shandong, China) (Produced by the province), pulverized, and mixed the antlers ganoderma powder at a ratio of 2.5% with the rat and rat standard 316979 200536486 feed AIN-93M (〇iieiital yeast (hereinafter referred to as 2.5% control food) as the three kinds of preparation The anti-tumor effects of staghorn ganoderma foods and products are discussed below. Prepared as a feed control in industrial (stock) manufacturing. The staghorn ganoderma lucidum with 2.5% of the control food can be used freely. ddY rats (Japanese SLC (stock) were divided into $ groups (10 per group), so that ddY rats were free to ingest only the three kinds of antler ganoderma lucidum food prepared above, 2.5% control food and standard feed AIN for rats and rats 93M (hereinafter referred to as food for control and group). After 1 week of breeding, 1 × 10 6 cells of Sarcoma80 sarcoma cells were inoculated subcutaneously in the chest of ddY mice as Sarcomal80 cancer-bearing mice. Continue to give 3 kinds of antler ganoderma lucidum food prepared above, 2 5% to J3, 、, food and 卩 卩, group food to feed Sarcoma 180 cancer mice. Eighteen days after subcutaneous implantation, the tumors were removed and their weights were measured. When the tumor weight of the control mice was taken as 100%, the tumor weight of each mouse was compared. The measurement results are shown in Table 3. [Table 3] Tumor weight (% of control group) 0.156% antler ganoderma food 62.7 0.625% antler ganoderma food 62.1 2.5% antler ganoderma food 46 — 2.5% control food 75T5 ^ From the table 3, there are three types In the case of staghorn ganoderma food, the antitumor activity increases with concentration. Furthermore, the antitumor activity of three kinds of antlers ganoderma lucidum food was shown to be stronger than that of 2.5% control food and control food Risi t 0 316979 23 200536486 ganoderma lucidum plus one product can be identified through Oral use also gives higher antitumor activity than untreated Ganoderma. (Experimental Example 6) The antitumor effect of Ganoderma lucidum treated with high temperature and high water vapor through oral ingestion is known only for the antlers Ganoderma lucidum used in Example M and Example 3 (water vapor treatment strip ^ :, 2 ′ ′, plus a force of h4MPa, 5 minutes) The same high temperature Wenbao Shuiluo gas treatment is carried out in the same way, not old ^ tired of tiredness + into the autoclave autoclave, dried, pulverized, and mixed with the standard feed for rats and rats at a ratio of 0.625 berry%. AIN-93M (Oriental Yeast Industry Co., Ltd.) is prepared into staghorn ganoderma lucidum food (hereinafter referred to as 0.625% staghorn ganoderma lucidum food). The staghorn ganoderma lucidum powder (commercial product, produced in Shandong Province, China) was crushed at a ratio of 2.5% to the standard feed for rats and rats AIN-93M (manufactured by 〇ientent Yeast Industry Co., Ltd.) and prepared into feed. (Hereinafter referred to as 25% control food) as a control. Use some food to explore the antitumor effect as follows. C3h rat (Japan

CharleS RlVer(股))分成5組(每1組I5隻),使C3H鼠分別 僅自由攝取上述調製的〇·625%鹿角靈芝食物、2 5%對照食 物、鼠、大鼠用標準飼料ΑΙΝ一93Μ (以下稱為對照組食 物)。經過1週的飼育後,於鼠的鼠頸部皮下接種2χΐ〇6個 細胞的ΜΜ46乳癌細胞,作為ΜΜ46罹癌鼠。皮下接種 28天後摘出腫瘤測定其重量,以對照鼠的腫瘤重量作為 100%時,比較每隻鼠的腫瘤重量。測定結果示於表4。 316979 24 200536486 【表4】 重量(ΐΠϋΖ^ζγ 64^6CharleS RlVer (shares) was divided into 5 groups (I5 per group), so that C3H rats were free to ingest only the above-prepared 0.625% staghorn ganoderma lucidum food, 2 5% control food, standard feed for rats and rats 93M (hereinafter referred to as the control food). After 1 week of rearing, MM46 breast cancer cells of 2 × 10 6 cells were inoculated subcutaneously in the rat's neck to obtain MM46 cancer-bearing mice. Twenty days after the subcutaneous inoculation, the tumor was removed and the weight of the tumor was measured. When the tumor weight of the control mouse was taken as 100%, the tumor weight of each mouse was compared. The measurement results are shown in Table 4. 316979 24 200536486 [Table 4] Weight (ΐΠϋZ ^ ζγ 64 ^ 6

Wm^K 盘2表4來看’可判別出本發明之U25%鹿角靈芝食物 罐理的鹿角靈芝食物(2.5%對照食物)比較之下,顯示 在1 /4的混合量仍有更強的抗腫瘤效果。換言之,可判別 籲出鹿角莖芝猎由高溫高麼水蒸氣處理能提高抗腫瘤活性。 ·(試驗例7)高溫高摩處理鹿角靈芝與抗癌化 _用效果 W J货 。不單獨使用醫藥品之lentinan或匕以加之來自蕈類的 抗癌多糖而與抗癌劑併用。因此探討關於本發明之高^高 壓處理鹿角靈芝萃取物與抗癌&學療法劑的併用效果。门 於C3H鼠的鼠頸部皮下接種2χ1〇6個細胞的mm46乳 癌細胞,作為MM46罹癌鼠。皮下接種i週後,以發生大 腫瘤者為基準以6組進行分組。以分別自由攝取試驗例$ 所凋製的0.1 56%鹿角靈芝食物、〇·625%鹿角靈芝食物、 2.5%鹿角靈芝食物、2 5%對照食物,還有對照組食物飼育 之。皮下接種13天後將抗癌化學療法劑環磷醯胺(CY)以 5〇 mg/kg的方式投與在腹腔内。對照組以對照組食物飼 育之,用代替CY的生理食鹽水等量投與腹腔内。皮下接 種2 8天後摘出腫瘤測定重量,以對照鼠的腫瘤重量作為 100%時’比較每隻鼠的腫瘤重量。測定結果示於表5。 316979 25 200536486 【表5】 腫瘤重量(對照組的°/〇) 0.156%鹿角靈芝食物(CY投與) 64.7 0.625%鹿角靈芝食物(CY投與) 50.9 2.5%鹿角靈芝食物(CY投與) 47.3 2.5%對照食物(CY投與) 60.5 對照組食物(CY投與) 64.8 對照組 100 根據表5,攝取3種鹿角靈芝食物或2.5%對照食物的 φ 組比單獨投與CY的組更能大幅抑制腫瘤增殖。進一步而 . 言,在比較3種鹿角靈芝食物與2.5 %對照食物的情況下, _ 也可判別出攝取0.625%鹿角靈芝食物和2.5%鹿角靈芝食 物能得到更強的抗腫瘤效果。進一步而言,根據這些結果, 可判別出本發明之靈芝加工品能與其他抗癌劑併用。再 者,本發明之鹿角靈芝加工品與以往的鹿角靈芝比較之 下,也可判別出與抗癌化學療法劑的併用效果較高。 (實施例4) ®鍵劑·· 根據以下所示方法,製造含有靈芝加工品的錠劑。 於高溫水蒸氣處理中使用高溫濕熱處理試驗裝置(曰 阪製作所(股)製造:HTS-25/ 140-8039)、蒸氣鍋爐(三浦 工業(股)製造:FH-100)。於SUS 316合金製的12L籃中 裝入切斷成1 cm片的鹿角靈芝1.5 kg,密閉在SUS 316 合金製的耐熱耐壓容器(30 L)内。於約1秒過程中送入使 用經由脫氧裝置(三浦工業(股)製造:DOR-1000P)脫氧的 26 316979 200536486 水(氧濃度為0.3 μ§/ml)所產生的高溫高壓飽和蒸氣置換 容器内的空氣後,在200°C,加壓壓力為1.4 MPa的高溫 _ 高壓狀態下保持300秒鐘。脫氣後,於反應容器變成80°C 以下時打開容器。接著,將上述所得鹿角靈芝的水蒸氣處 理物添加24 L水,進行2次121°C,30分鐘的萃取(高壓 蚤萃取),得到鹿角靈芝萃取物。將此萃取物凍乾,得到約 450 g的靈芝加工品A。 使6 6 · 7 mg的此靈芝加工品A、23 2 ·0 mg的乳糖及1 · 3 φ mg的硬脂酸鎂同時混合,藉由在單發式打錠機中打錠,製 ^ 造直徑為1 0 mm,重量為300 mg的鍵劑。 _ (實施例5) 萃取物: 使與實施例3同樣實施所得到的鹿角靈芝萃取物濃縮 成10%(W/W)的白利(brix),得到濃縮萃取物(靈芝加工品 B)。此靈芝加工品B用無菌水進行1 0倍稀釋裝入袋中。 (實施例6) 鲁顆粒劑1 ·· 在99.5 g與實施例3同樣實施所得到的靈芝加工品A 中,添加0.5 g的硬脂酸鎂,壓縮、粉碎、整粒,篩選得 到20至50 mesh的顆粒劑。 (實施例7) 顆粒劑2 : 使與實施例3同樣進行高溫高壓水蒸氣處理之鹿角靈 芝的水蒸氣處理物,在不進行添加水或高壓爸萃取的乾燥 27 316979 200536486 後,藉由使乾燥物粉末化為200 mesh的大小而調製靈芝加 工品C。於1.0 g的此靈芝加工品中添加0.4 g的、0.1 g ^ 的澱粉造粒,篩選得到20至50 mesh的顆粒劑。 (實施例8) 靈芝萃取飲料(靈芝茶飲料) 取200 g實施例6所得的靈芝加工品C,用5 L的水(90 °C )進行滴液萃取。所得萃取液經離心、過濾後,添加1.7 g 維生素C、3.4 g碳酸氫鈉及水成為17 L。使所得混合液升 鲁溫至約85°C後,充填於190 g的罐中,進行蒸餾罐殺菌(125 .t,14分),得到20瓶靈芝萃取飲料(靈芝茶飲料)。所得 . 靈芝萃取飲料附上「抗腫瘤食品」的標示。 (實施例9) 分別使用由實施例3所得之靈芝加工品A、由實施例 4所得之靈芝加工品B、由實施例5所得之靈芝加工品C, 以下列所示組成,根據常用方法製造掺入靈芝加工品的各 種飲食品。 (實施例9-1) 糖: 【表6】 組成_重量份 山梨糖醇粉 99^7~~ 香料 0.2 靈芝加工品B 0.05 山梨糖醇晶種 0.05 全部重量 100.00 28 316979 200536486Wm ^ K Disk 2 Table 4 Look at the comparison of the antlers and ganoderma lucidum food (2.5% control food) of the U25% antler ganoderma lucidum food can be discriminated according to the present invention, showing that the mixing amount of 1/4 is still stronger. Antitumor effect. In other words, it can be discerned that the treatment of staghorn stalks by high temperature and high water vapor treatment can improve the antitumor activity. · (Experiment Example 7) Treatment of staghorn lucid ganoderma with high temperature and high friction and anti-cancer effect _ with effect W J goods. Do not use lentinan or dagger of pharmaceuticals alone with anticancer polysaccharides derived from mushrooms and use with anticancer agents. Therefore, the combined effects of the high-pressure and high-pressure-treated antlers ganoderma lucidum extract and the anticancer & therapeutic agent of the present invention are discussed. C3H mice were subcutaneously inoculated with 2x106 cells of mm46 breast cancer cells subcutaneously as MM46 cancer-bearing mice. After i week of subcutaneous inoculation, the group was divided into 6 groups based on those with large tumors. 0.1 56% staghorn ganoderma lucidum food, 0.625% staghorn ganoderma lucidum food, 2.5% staghorn ganoderma lucidum food, and 25% 5% control food and control group food were freely ingested. Thirteen days after subcutaneous inoculation, the anticancer chemotherapy agent cyclophosphamide (CY) was administered to the abdominal cavity at 50 mg / kg. The control group was fed with control group food, and the same amount of physiological saline instead of CY was administered into the abdominal cavity. After 28 days from subcutaneous implantation, the tumors were removed and their weights were measured. The tumor weights of the control mice were taken as 100% and the tumor weights of each mouse were compared. The measurement results are shown in Table 5. 316979 25 200536486 [Table 5] Tumor weight (° / 〇 in control group) 0.156% Antler Ganoderma food (CY administration) 64.7 0.625% Antler Ganoderma food (CY administration) 50.9 2.5% Antler Ganoderma food (CY administration) 47.3 2.5% control food (CY administration) 60.5 Control food (CY administration) 64.8 Control group 100 According to Table 5, the φ group ingesting 3 kinds of antler ganoderma lucidum food or 2.5% control food was more significant than the CY group alone Inhibit tumor proliferation. Furthermore, in the case of comparing three kinds of antler ganoderma lucidum food with 2.5% control food, _ can also be judged that ingesting 0.625% antler ganoderma lucidum food and 2.5% antler ganoderma lucidum food can obtain a stronger antitumor effect. Furthermore, based on these results, it can be determined that the processed Ganoderma lucidum product of the present invention can be used in combination with other anticancer agents. Furthermore, compared with the conventional staghorn ganoderma lucidum processed product of the present invention, it can be judged that the combined effect with an anticancer chemotherapeutic agent is high. (Example 4) ® Bonding agent ... A tablet containing a processed product of ganoderma was produced by the method shown below. For high-temperature water vapor treatment, a high-temperature wet heat treatment test device (Saidaka Co., Ltd .: HTS-25 / 140-8039), and a steam boiler (Miura Industrial Co., Ltd .: FH-100) were used. In a 12L basket made of SUS 316 alloy, 1.5 kg of staghorn lucid ganoderma cut into 1 cm pieces was placed and sealed in a heat-resistant and pressure-resistant container (30 L) made of SUS 316 alloy. In approximately 1 second, it is sent to a high-temperature, high-pressure saturated vapor replacement vessel using 26 316979 200536486 water (oxygen concentration 0.3 μ§ / ml) deoxidized by a deoxidizer (Muraura Industrial Co., Ltd .: DOR-1000P). After the air, it is held at 200 ° C for 300 seconds under a high temperature and high pressure state of 1.4 MPa. After degassing, open the container when the reaction container becomes below 80 ° C. Next, 24 L of water was added to the steam treatment of the antler ganoderma obtained above, and extraction was performed twice at 121 ° C for 30 minutes (high pressure flea extraction) to obtain an antler ganoderma extract. This extract was lyophilized to obtain about 450 g of Ganoderma processed product A. 6 6 · 7 mg of this Ganoderma Lucidum processed product A, 23 2 · 0 mg of lactose, and 1 · 3 φ mg of magnesium stearate were mixed at the same time. A bond with a diameter of 10 mm and a weight of 300 mg. (Example 5) Extract: The staghorn ganoderma extract obtained in the same manner as in Example 3 was concentrated to 10% (W / W) brix to obtain a concentrated extract (processed Ganoderma lucidum B). This Ganoderma lucidum processed product B was diluted 10 times with sterile water and put into a bag. (Example 6) Lu granules 1 ··················································································· granules of mesh. (Example 7) Granule 2: The steam-treated product of staghorn lucid ganoderma that was subjected to high-temperature and high-pressure steam treatment in the same manner as in Example 3 was dried without adding water or high-pressure extraction. 27 316979 200536486 The material was powdered to a size of 200 mesh to prepare Ganoderma lucidum processed product C. 0.4 g of 0.1 g ^ of starch was added to 1.0 g of this Ganoderma processed product to obtain granules of 20 to 50 mesh. (Example 8) Ganoderma lucidum extract beverage (ganoderma tea beverage) 200 g of the processed ganoderma lucidum product C obtained in Example 6 was subjected to dropwise extraction with 5 L of water (90 ° C). After the obtained extract was centrifuged and filtered, 1.7 g of vitamin C, 3.4 g of sodium bicarbonate and water were added to make 17 L. After the resulting mixed solution was brought to a temperature of about 85 ° C., it was filled in a 190 g jar and sterilized by a distillation tank (125 .t, 14 minutes) to obtain 20 bottles of ganoderma extract beverage (ganoderma tea beverage). Result. Ganoderma lucidum extract is labeled with "anti-tumor food". (Example 9) Each of Ganoderma processed product A obtained in Example 3, Ganoderma processed product B obtained in Example 4, and Ganoderma processed product C obtained in Example 5 was used according to the following composition and manufactured according to a common method. Various foods and drinks mixed with processed ganoderma. (Example 9-1) Sugar: [Table 6] Composition_weight parts Sorbitol powder 99 ^ 7 ~~ Spice 0.2 Ganoderma processed product B 0.05 Sorbitol seed 0.05 Total weight 100.00 28 316979 200536486

(實施例9-2) 糖果: 【表7】 組成 重量份 砂糖 47.0 麥芽糖 49.76 香料 1.0 水 2.0 靈芝加工品B 0.24 全部重量 100.00 (實施例9-3) 糖錠: 【表8】 組成 重量份 阿拉伯樹膠 6.00 葡萄糖 73.00 靈芝加工品A 0.05 鱗酸氫二鉀 0.20 石粦酸~一氮钟 0.10 乳糖 17.00 香料 0.10 硬脂酸鎂 3.55 全部重量 100.00 (實施例9-4) 口香糖: 29 316979 200536486 【表9】 組成 重量份 .口香糖基質 碳酸鈣 蛇菊脊 靈芝加工品C 乳糖 香料 20.00 2.00 0.10 0.05 76.85 1.00 全部重量 100.00 (實施例9-5) ’果凍(咖啡果凍): 【表10】 - 組成 重量份 精製細砂糖 明膠 咖啡萃取物 水 靈芝加工品B 15.00 1.00 5.00 78.93 0.07 全部重量 • (實施例9-6) 水羊羹: 100.00 30 316979 200536486 [表11】 組成 重量份 紅色生铭 24.80 瓊脂粉 0.30 食鹽 0.10 上等白糖 24.90 靈芝加工品B 0.10 水 49.80 全部重量 100.00 (實施例9-7) 果汁= 【表12】 組成 重量份 冷凍濃縮溫州柑桔果汁 5.00 果糖葡萄糖液狀糖 11.00 檸檬酸 0.20 L-抗壞血·酸 0.02 靈芝加工品B 0.05 香料 0.20 色素 0.10 水 83.43 全部重量 100.00 (實施例9-8) 碳酸飲料: 31 316979 200536486 【表13】 組成 重量份 精製細砂糖 8.00 濃縮檸檬果汁 1.00 L-抗壞血酸 0.10 檸檬酸 0.09 檸檬酸納 0.05 著色料 0.05 香料 0.15 碳酸水 90.55 靈芝加工品B 0.01 全部重量 100.00 (實施例9-9) 乳酸囷飲料· 【表14】 組成 重量份 乳固體成分為21%的醱酵乳 14.76 果糖葡萄糖液狀糖 13.31 果膠 0.50 檸檬酸 0.08 香料 0.15 水 71.14 靈芝加工品B 0.06 全部重量 100.00 (實施例9-10) 咖σ非飲料: 32 316979 200536486 [表15】 組成 重量份 精製細砂糖 Too~' 脫脂奶粉 5.00 焦糖 0.20 咖°非萃取物 2.00 香料 0.10 聚甘油脂肪酸酯 0.05 食鹽 0.05 水 84.56 靈芝加工品B 全部重量 ^~T〇〇T〇^ (實施例9-11) 酒精飲料: 【表16】 ϋι分 ^32Τ〇〇 8.40 2.40 0.20 ΤοοΤο? 組成 I容的 砂糖 果汁 靈芝加工品B 純水 (產業上利用的可能性) 作用造方法,能工業上有利地製造抗腫瘤 物或靈芝=:=物或靈芝加工品,所製造的靈芝卢 癌 疒心者有極大效果者,其 〜疋對於 屋業上為大貝獻度者。(Example 9-2) Candy: [Table 7] Composition weight parts Granulated sugar 47.0 Maltose 49.76 Spice 1.0 Water 2.0 Ganoderma processed product 0.2 0.2 Total weight 100.00 (Example 9-3) Sugar lozenge: [Table 8] Composition weight parts Arab Gum 6.00 Glucose 73.00 Ganoderma lucidum processed product A 0.05 Dipotassium hydrogen phosphate 0.20 Carnic acid ~ monoazine 0.10 Lactose 17.00 Spice 0.10 Magnesium stearate 3.55 Total weight 100.00 (Example 9-4) Chewing gum: 29 316979 200536486 [Table 9 ] Composition parts by weight. Chewing gum base calcium carbonate Stevia chinensis Ganoderma processed product C Lactose flavor 20.00 2.00 0.10 0.05 76.85 1.00 Total weight 100.00 (Example 9-5) 'Jelly (coffee jelly): [Table 10]-Composition weight parts refined Fine sugar gelatin coffee extract Water Ganoderma Lucidum processed product B 15.00 1.00 5.00 78.93 0.07 Total weight • (Example 9-6) Water goat's gizzard: 100.00 30 316979 200536486 [Table 11] Composition weight parts of red shengming 24.80 agar powder 0.30 salt 0.10 on Equivalent sugar 24.90 Ganoderma processed product B 0.10 Water 49.80 Total weight 100.00 (Example 9-7) Juice = [Table 12] Composition weight parts Frozen concentrated Wenzhou citrus fruit juice 5.00 Fructose glucose liquid sugar 11.00 Citric acid 0.20 L-ascorbic acid · 0.02 Ganoderma processed product B 0.05 Spice 0.20 Pigment 0.10 Water 83.43 Total weight 100.00 (Example 9- 8) Carbonated beverage: 31 316979 200536486 [Table 13] Composition weight parts refined sugar 8.00 concentrated lemon juice 1.00 L-ascorbic acid 0.10 citric acid 0.09 sodium citrate 0.05 coloring material 0.05 spice 0.15 carbonated water 90.55 processed ganoderma lucidum B 0.01 total weight 100.00 (Examples 9-9) Lactobacillus lactic acid beverages [Table 14] Composition weight parts of fermented milk with 21% milk solid content 14.76 Fructose glucose liquid sugar 13.31 Pectin 0.50 Citric acid 0.08 Spice 0.15 Water 71.14 Ganoderma processed product B 0.06 All Weight 100.00 (Examples 9-10) Coffee σ non-beverage: 32 316979 200536486 [Table 15] Composition weight parts refined sugar Too ~ 'skim milk powder 5.00 caramel 0.20 coffee ° non-extract 2.00 flavor 0.10 polyglycerol fatty acid ester 0.05 Salt 0.05 Water 84.56 Ganoderma processed product B Total weight ^ ~ T〇〇T〇 ^ (Examples 9-11) Alcoholic beverages: [Table 16] 分 ι ^^ Τ〇〇8.40 2.40 0.20 ΤοοΤο? Sugar juice, Ganoderma lucidum processed product B, which has a content of 1 volume, pure water (industrial possibility) Action method, It can industrially manufacture antitumor substances or Ganoderma lucidum =: = objects or processed products of Ganoderma lucidum. Those who have made Ganoderma lucidum cancer carers have great effects, and they are very important for the housing industry.

I 33 3i6979 200536486 [圖式簡單說明] 第1圖表示試驗例3之萃取率的測定結果。 第2圖表示試驗例4之/5-葡聚糖的溶解析出量。I 33 3i6979 200536486 [Brief description of the drawings] Fig. 1 shows the measurement results of the extraction rate in Test Example 3. FIG. 2 shows the elution amount of / 5-glucan in Test Example 4. FIG.

34 31697934 316979

Claims (1)

200536486 十、申請專利範圍: • 1. 一種靈芝處理物之製造方法,其特徵為··以1 50直2 1 0 - C的水蒸氣處理靈芝。 2·如申請專利範圍第1項的靈芝處理物之製造方法,其 中’係以1 80至21 0°C的水蒸氣進行處理。 3·如申請專利範圍第1或2項的靈芝處理物之製造方法, 其中’該水蒸氣為飽和水蒸氣。 4·如申凊專利範圍第1至3項中任一項的靈芝處理物之製 _ 造方法,其中,該處理係於〇至1 #g/mL的氧濃度下 進行。 5·:申凊專利範圍第1至4項中任-項的靈芝處理物之製 仏方去,其中,係進行水蒸氣處理1至30分鐘。 取工芝處理物,係含有〇.5重量%以上的水溶性0-葡 ‘I;圍=利範圍第6項之靈芝處理物,係利用申請專利 8.—種靈一 f 5項中任一項的製造方法製得者。 f , 〇工°〇Q之製造方法’其特徵為: 處理…呢的水蒸氣處理靈芝所得到的靈芝 Ο男切或粉末化, 2) 用水性溶劑萃取,或 3) 使前述2) 化。 仔萃取液進—步濃縮提煉或乾燥粉末 9·—種靈芝加工D D衣造方法,其特徵為:以150至21〇 316979 35 200536486 °c的水萃取靈芝,或是使該水萃取物進一步濃縮提煉或 乾燥粉末化。 10·如申請專利範圍第9項的靈芝加工品之製造方法,其 中,提取為原料靈芝之0.5重量%以上之比率的水溶性 P-葡聚糖於靈芝加工品中。 11·一種靈芝加工品,係利用申請專利範圍第8、9或10項 之製造方法製得者。 12.—種飲食品,係含有申請專利範圍第6或7項之靈芝處 理物,或申請專利範圍第11項之靈芝加工品。 13·如申請專利範圍第12項之飲食品,其附有以抗腫瘤作 用、免疫活化作用或抗癌作用為主旨的標示。 14·一種醫藥品,係含有申請專利範圍第6或7項之靈芝處 理物,或申請專利範圍第11項之靈芝加工品。 15.如申請專利範圍第14項之醫藥品,該醫藥品為抗腫瘤 劑0200536486 10. Scope of patent application: 1. A method for manufacturing Ganoderma lucidum treatment, which is characterized by treating Ganoderma lucidum with water vapor of 1 50 to 2 1 0-C. 2. The method for manufacturing a Ganoderma lucidum treated product according to item 1 of the patent application scope, wherein ′ is treated with water vapor at 180 to 21 ° C. 3. The method for manufacturing a Ganoderma treatment product according to item 1 or 2 of the scope of patent application, wherein 'the water vapor is saturated water vapor. 4. The method for manufacturing a Ganoderma lucidum treatment product according to any one of claims 1 to 3 in the patent application scope, wherein the treatment is performed at an oxygen concentration of 0 to 1 # g / mL. 5 ·: The preparation of Ganoderma lucidum treated products in any one of items 1 to 4 of the patent scope, in which the water vapor treatment is performed for 1 to 30 minutes. Taken Zhizhi treatment, which contains 0.5% by weight or more of water-soluble 0-glucose 'I; Wai = Ganoderma lucidum treatment in the sixth item of the scope, using the patent application 8.-Zhonglingyi f 5 Produced by a manufacturing method. f, 〇 工 ° 〇Q 的 制造 方法 ’is characterized in that: Ganoderma lucidum obtained by treating Ganoderma with water vapor treated with o is cut or powdered, 2) is extracted with an aqueous solvent, or 3) is converted into 2). Aberdeen extract is further concentrated and refined or dried powder. 9 · A method for processing DD garments of Ganoderma lucidum, which is characterized by extracting Ganoderma lucidum with water from 150 to 21 0316979 35 200536486 ° C, or further concentrating the water extract. Refined or dried to powder. 10. The method for manufacturing a processed Ganoderma lucidum product according to item 9 of the patent application scope, wherein the water-soluble P-glucan is extracted into the processed Ganoderma lucidum product at a ratio of 0.5% by weight or more of the raw material Ganoderma lucidum. 11. A processed Ganoderma lucidum, which is manufactured by using the manufacturing method of the patent application No. 8, 9, or 10. 12. A food and drink product containing processed Ganoderma lucidum under the scope of patent application No. 6 or 7 or processed Ganoderma lucidum under the scope of patent application No. 11. 13. If the food or beverage of item 12 of the patent application scope is attached, it has a label with the main purpose of anti-tumor effect, immune activation effect or anti-cancer effect. 14. A pharmaceutical product, which contains processed Ganoderma lucidum in the scope of patent application No. 6 or 7, or processed Ganoderma lucidum in the scope of patent application No. 11. 15. If the medicine in the scope of patent application No. 14 is applied, the medicine is an antitumor agent. 36 31697936 316979
TW094112843A 2004-04-28 2005-04-22 Treated ganoderma lucidum and manufacturing method of processed product of ganoderma lucidum TW200536486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004134761 2004-04-28

Publications (1)

Publication Number Publication Date
TW200536486A true TW200536486A (en) 2005-11-16

Family

ID=35241436

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094112843A TW200536486A (en) 2004-04-28 2005-04-22 Treated ganoderma lucidum and manufacturing method of processed product of ganoderma lucidum

Country Status (3)

Country Link
JP (1) JPWO2005105128A1 (en)
TW (1) TW200536486A (en)
WO (1) WO2005105128A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107602719A (en) * 2017-10-20 2018-01-19 广东粤微食用菌技术有限公司 A kind of ganoderma lucidum fruitbody refined polysaccharide with notable adjunct antineoplastic activity and its preparation method and application
CN107722131A (en) * 2017-10-20 2018-02-23 广东粤微食用菌技术有限公司 A kind of total ganoderma spore powder refined polysaccharide with notable adjunct antineoplastic activity and its preparation method and application
CN111280287A (en) * 2020-03-30 2020-06-16 陕西科技大学 Goat milk edible fungus ice cream with effects of dispelling effects of alcohol and protecting liver and preparation method thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006282580A (en) * 2005-03-31 2006-10-19 Kobayashi Pharmaceut Co Ltd Method for obtaining bioactive component derived from mushroom
JP2006282847A (en) * 2005-03-31 2006-10-19 Kobayashi Pharmaceut Co Ltd Method for acquiring bioactive component derived from mushroom
JP2007045713A (en) * 2005-08-05 2007-02-22 Iskra Ind Co Ltd Extract of spore of ganoderma lucidum and preparation of spore of ganoderma lucidum
JP5249559B2 (en) * 2006-11-09 2013-07-31 株式会社ミゾタ Extraction method and apparatus of useful substances from Kazuno Ganoderma
JP2014090711A (en) * 2012-11-07 2014-05-19 Yamato Kanpo Kk Method for processing deer horn shaped ganoderma lucidum, deer horn shaped ganoderma lucidum-processed product, and food and drink
CN104872624B (en) * 2015-05-08 2017-10-17 苏州葛家坞生物科技有限公司 A kind of preparation method of ganoderma lucidum instant leisure food
CN113951356A (en) * 2021-10-15 2022-01-21 上海舒泽生物科技研究所 Mushroom and ganoderma lucidum polysaccharide composite tablet candy for improving immunity and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3212940B2 (en) * 1998-03-02 2001-09-25 眞悟 菊地 A method for efficiently extracting extracts from Reishi (Mushroom)
JP2001187745A (en) * 1999-12-28 2001-07-10 Joyaku Kenkyusho:Kk Bioactive extract from ganoderas lucidum and health food using the same extract

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107602719A (en) * 2017-10-20 2018-01-19 广东粤微食用菌技术有限公司 A kind of ganoderma lucidum fruitbody refined polysaccharide with notable adjunct antineoplastic activity and its preparation method and application
CN107722131A (en) * 2017-10-20 2018-02-23 广东粤微食用菌技术有限公司 A kind of total ganoderma spore powder refined polysaccharide with notable adjunct antineoplastic activity and its preparation method and application
CN111280287A (en) * 2020-03-30 2020-06-16 陕西科技大学 Goat milk edible fungus ice cream with effects of dispelling effects of alcohol and protecting liver and preparation method thereof

Also Published As

Publication number Publication date
WO2005105128A1 (en) 2005-11-10
JPWO2005105128A1 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
TW200536486A (en) Treated ganoderma lucidum and manufacturing method of processed product of ganoderma lucidum
CN102293381A (en) Instant asparagus powder
CN107427055B (en) Preparation method of fermented red ginseng powder dispersion liquid and preparation method of red ginseng nano powder
Choi et al. Enhancement of anti-complementary and radical scavenging activities in the submerged culture of Cordyceps sinensis by addition of citrus peel
JP2020506683A (en) A composition for enhancing immunity containing ginseng berry polysaccharide
KR20210060864A (en) Fermented broth comprising ginsenoside originated the leaf of ginseng and manufacturing method thereof
KR102478724B1 (en) A composition for diabetes or cardiovascular disease treatment comprising a citrus fermented kombucha
KR101709281B1 (en) Composition for Prevention or Treatment of Osteoporosis Comprising Herbal Extract and Fermentation Product thereof with Lactic acid Bacteria
KR20220136107A (en) Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same
CN104055119B (en) A kind of female health lozenge prepared by Tea Flower and pueraria root powder
JP2002138046A (en) Nk cell activator
US20230241147A1 (en) Method for improving preparation of fermented black ginseng containing high content of functional ingredients based on safety by applying led
KR102230517B1 (en) Lactobacillus salivarius having anticariogenic activities and composition comprising the same
KR101718611B1 (en) Novel microorganism producing carotinoid
JP2011173857A (en) Immune function-enhancing composition containing paper mulberry extract
KR20140105657A (en) A comprising an extracts of fermented Schisandra chinensis Baillon showing anti-oxidative, anti-hypertensive activity
JP5081485B2 (en) Anticancer agent and method for producing anticancer agent
JP2013237652A (en) Cancer suppression composition containing papaya fermentation product as active ingredient
KR101683030B1 (en) A composition comprising the extract of fermented Curcuma longa L. and the compound extracted therefrom for preventing and treatment of cancer
KR102210092B1 (en) Lactobacillus reuteri MG505 having anticariogenic activities and composition comprising the same
KR102244732B1 (en) Probiotic acetic acid bacteria Acetobacter pasteurianus MGLV and its immunomodulatory effect
KR20130069206A (en) Novel enterococcus sp with immune-enhancing activity and its use
JP6044944B2 (en) Process for producing new processed ume products and functional composition, food composition, and pharmaceutical composition using the same
KR101975018B1 (en) Composition for lowering cholesterol comprising a mixture culture of Ginseng Berry-Auricularia auricula mycelia
KR20090093619A (en) Anti-helicobacter composition containing schizandra sp extract and rubus careabus extract